{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions ss"],"components":["Active, inactive dwd"],"effective_time":"20190516","id":"8902e7d5-cdb1-1ca1-e053-2995a90a951f","instructions_for_use":["Directions for use sd"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 5158-2 NIACINAMIDE USP 4% / TACROLIMUS USP 0.03%. Ointment 30gm. fd"],"set_id":"8902e7d5-cdb0-1ca1-e053-2995a90a951f","spl_product_data_elements":["NIACINAMIDE 4% / TACROLIMUS 0.03% NIACINAMIDE 4% / TACROLIMUS 0.03% TACROLIMUS TACROLIMUS ANHYDROUS NIACINAMIDE NIACINAMIDE clear ointment"],"version":"1"}